A signature of <i>Prevotella copri</i> and <i>Faecalibacterium prausnitzii</i> depletion, and a link with bacterial glutamate degradation in the Kenyan colorectal cancer patientsOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This single-center study profiled the gut mucosa-associated microbiome of Kenyan colorectal cancer (CRC) patients and healthy volunteers. Researchers used 16S rRNA sequencing to characterize microbial community composition, examining alpha and beta diversity, differential taxa abundance, and predicted microbial metabolic profiles. The study also evaluated associations between microbiome profiles and patient age, motivated by rising and increasingly early-onset CRC incidence in Kenya.
Who was studied?
The cohort consisted of 18 CRC patients and 18 healthy controls recruited at the Moi Teaching and Referral Hospital, Moi University, in Kenya. This population was chosen because microbiome studies in Kenyan CRC patients are rare, despite CRC incidence rates tripling in the country between 1997 and 2017. The hospital has also observed an increase in CRC diagnoses among younger patients.
What were the most important findings?
Alpha diversity did not differ significantly between CRC patients and healthy controls, but beta diversity metrics showed clear dissimilarities in overall microbial community structure between the two groups. The most notably underrepresented species in the CRC group were Prevotella copri and Faecalibacterium prausnitzii, an anti-inflammatory, butyrate-associated commensal. The abstract also points to an association with bacterial glutamate degradation pathways as part of the CRC-associated microbial signature.
What are the greatest implications of this study?
The findings suggest that gut microbiome dysbiosis, marked by loss of key commensals like Faecalibacterium prausnitzii and Prevotella copri, may contribute to CRC pathobiology in a Kenyan population that has been understudied in microbiome research. Because overall diversity was preserved while community composition shifted, compositional and functional changes rather than diversity loss appear more relevant to CRC in this setting. These results support further investigation of microbiome signatures, including glutamate metabolism pathways, as potential contributors to the rising and increasingly early-onset CRC burden in Sub-Saharan Africa.